BioCentury | Jan 15, 2021
Finance

Armed with newer data, $196M, NewAmsterdam hopes to resuscitate well-traveled CETP dyslipidemia program

...Population Health Partners, Peter Thiel, Janus Henderson Investors, Medpace, GL Capital, JVC Investment Partners and Presight Capital.TARGETSCETP...
BioCentury | Jan 12, 2021
Finance

Jan. 11 Quick Takes: Megarounds for Valo, Visen; plus NuProbe, Sensei

...as well as existing investors Cambrian Biopharma, Moore Strategic Ventures, Steve Jurvetson’s Future Ventures and Presight Capital...
BioCentury | Dec 21, 2020
Finance

Dec. 21-23 Financial Quick Takes: Venture rounds for SomaLogic, ONL; plus Jacobio’s HK listing, Cullinan, Gracell and Zhaoke file for IPOs, and more

...and development company Peptilogics Inc. raised $35.4 million in a series B round led by Presight Capital...
BioCentury | May 28, 2020
Finance

Fresh off Lilly deal, AbCellera readies to deploy $105M to streamline antibody-based R&D

...Global Investors, Peter Thiel, Founders Fund, Eli Lilly and Co. (NYSE:LLY), University of Minnesota and Presight Capital...
BioCentury | Feb 19, 2020
Finance

Feb. 19 Financial Quick Takes: bluebird's delayed BLA timeline, plus fundings for NeoTx, Scipher and EnClear

...round led by 20/20 HealthCare Partners; also participating were Peter Thiel, Amgen Ventures, GHS Fund, Presight Capital...
Items per page:
1 - 5 of 5
BioCentury | Jan 15, 2021
Finance

Armed with newer data, $196M, NewAmsterdam hopes to resuscitate well-traveled CETP dyslipidemia program

...Population Health Partners, Peter Thiel, Janus Henderson Investors, Medpace, GL Capital, JVC Investment Partners and Presight Capital.TARGETSCETP...
BioCentury | Jan 12, 2021
Finance

Jan. 11 Quick Takes: Megarounds for Valo, Visen; plus NuProbe, Sensei

...as well as existing investors Cambrian Biopharma, Moore Strategic Ventures, Steve Jurvetson’s Future Ventures and Presight Capital...
BioCentury | Dec 21, 2020
Finance

Dec. 21-23 Financial Quick Takes: Venture rounds for SomaLogic, ONL; plus Jacobio’s HK listing, Cullinan, Gracell and Zhaoke file for IPOs, and more

...and development company Peptilogics Inc. raised $35.4 million in a series B round led by Presight Capital...
BioCentury | May 28, 2020
Finance

Fresh off Lilly deal, AbCellera readies to deploy $105M to streamline antibody-based R&D

...Global Investors, Peter Thiel, Founders Fund, Eli Lilly and Co. (NYSE:LLY), University of Minnesota and Presight Capital...
BioCentury | Feb 19, 2020
Finance

Feb. 19 Financial Quick Takes: bluebird's delayed BLA timeline, plus fundings for NeoTx, Scipher and EnClear

...round led by 20/20 HealthCare Partners; also participating were Peter Thiel, Amgen Ventures, GHS Fund, Presight Capital...
Items per page:
1 - 5 of 5